365 related articles for article (PubMed ID: 8821858)
1. Age-independent indices in second-trimester serum screening for Down's syndrome are useless.
Zimmermann R; Reynolds TM; John R; Spencer K; Bartels I; Coombes E; Trevor S
Prenat Diagn; 1996 Jan; 16(1):79-82. PubMed ID: 8821858
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
3. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Hsu JJ; Hsieh TT; Soong YK; Spencer K
Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
[TBL] [Abstract][Full Text] [Related]
5. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
6. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum markers for Down's syndrome pregnancies.
Chew S; Anandakumar C; Ratnam SS
Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160
[TBL] [Abstract][Full Text] [Related]
8. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Extermann P; Bischof P; Marguerat P; Mermillod B
Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
[TBL] [Abstract][Full Text] [Related]
9. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK
Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604
[TBL] [Abstract][Full Text] [Related]
10. The role of maternal serum alpha-fetoprotein, human chorionic gonadotrophin and oestriol in the antenatal screening of Down's syndrome.
Chang TC; Cheng HH
Med J Malaysia; 1994 Dec; 49(4):351-4. PubMed ID: 7545778
[TBL] [Abstract][Full Text] [Related]
11. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
Reynolds T; Ellis A; Jones R
Ann Clin Biochem; 2004 Nov; 41(Pt 6):464-8. PubMed ID: 15588435
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].
Yu DY; Fu P; Zhang ZH; Wang F; Han MY; Ren HY; Zhao W; Zhang K; Li S; Jiang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):332-5. PubMed ID: 21644235
[TBL] [Abstract][Full Text] [Related]
13. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM
Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244
[TBL] [Abstract][Full Text] [Related]
14. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
[TBL] [Abstract][Full Text] [Related]
15. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
16. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
[TBL] [Abstract][Full Text] [Related]
17. [Serum screening of pregnant women reveals Down syndrome. Analysis of biochemical markers for earlier detection].
Christiansen M; Larsen SO; Nørgaard-Pedersen B
Lakartidningen; 1997 Dec; 94(51-52):4898-902. PubMed ID: 9454010
[TBL] [Abstract][Full Text] [Related]
18. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
19. Effect of gravidity on maternal serum markers for Down's syndrome.
Barkai G; Goldman B; Ries L; Chaki R; Cuckle H
Prenat Diagn; 1996 Apr; 16(4):319-22. PubMed ID: 8734805
[TBL] [Abstract][Full Text] [Related]
20. Down's syndrome: current screening techniques.
White RS
South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
